Laryngeal chondrosarcoma: a population-based analysis.

Area of Science:

• Oncology
• Laryngology
• Epidemiology

Background:

• Laryngeal chondrosarcoma (LC) is an exceptionally rare tumor, accounting for less than 1% of all laryngeal neoplasms.
• The rarity of LC poses challenges in studying its incidence and patient survival trends.

Purpose of the Study:

• To evaluate the incidence of laryngeal chondrosarcoma (LC) by patient demographics.
• To analyze long-term survival trends for LC using a population-based database.

Main Methods:

• Retrospective analysis of the Surveillance, Epidemiology, and End Results (SEER) registry.
• Inclusion of 143 patients diagnosed with LC between 1973 and 2010.
• Analysis of patient demographics, incidence, treatment, and survival data.

Main Results:

• LC represents 0.2% of laryngeal tumors, with a median age at diagnosis of 61.7 years; 76.2% of patients were male.
• Tumors were predominantly locally invasive (37.7% T4), with infrequent metastases.
• Disease-specific survival for LC at 1, 5, and 10 years was 96.5%, 88.6%, and 84.8%, significantly better than other laryngeal tumors (P < 0.01).

Conclusions:

• This study provides the largest sample size to date for evaluating LC incidence and survival.
• Laryngeal chondrosarcoma is a rare, locally invasive malignancy with a rare propensity for metastasis.
• The prognosis for laryngeal chondrosarcoma is considerably more favorable compared to other laryngeal malignancies.